26 Paul Tudor Jones II Agenus Trades
The first Agenus trade was made in Q4 2013. Since then Paul Tudor Jones II bought shares twelve more times and sold shares on thirteen occasions. The investor completely sold their stake between Q2 2023 and Q1 2024.
News about Agenus Inc and Paul Tudor Jones II
GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
LEXINGTON, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapies and adjuva...
GSK’s RSV vaccine candidate for older adults, containing Agenus’ QS-21 STIMULON™ as part of GSK’s AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissions
LEXINGTON, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapies and adjuvants d...
Agenus Posts Early Data For CTLA-4 Drug Candidate Across Tumor Types
In a Phase I study across nine tumor types, Agenus Incs (NASDAQ: AGEN ) CTLA-4 drug AGN1181 posted one complete response and three partial responses (PRs) as...